Brown University

brown.edu

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

281

Active

56

Phase 3

9

Total enrollment

360,717

Pipeline matrix

Showing 29 of 29 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Arm I Carboplatin, Paclitaxel, Pembrolizumab1
Arm II Carboplatin, Paclitaxel, Cetuximab1
Arm III Pembrolizumab1
Hydroxyurea1
Nivolumab4
Ipilimumab2
Lenalidomide2
Doxazosin2
Regular Human Insulin then Placebo1
ASP-1929 photoimmunotherapy1
Tafasitamab1
Polatuzumab vedotin1
Glofitamab1
Obinutuzumab1
Trastuzumab deruxtecan1
Mosunetuzumab1
Probenecid Oral1
Dexamethasone1
Ipilumumab1
Rucaparib1
Copanlisib1
THC-dominant cannabis1
CBD-dominant cannabis1
Cannabis placebo1
Alcohol1
Alcohol placebo1
Gemtuzumab Ozogamicin1
yttrium-90 radioembolization1
ACM-CpG1

Next readouts

  • 2019-03
  • 2023-09-26
  • 2025-05-05
  • 2026-06
  • 2026-06
  • 2026-06-01
  • 2026-08-31
  • 2026-09-01
  • 2026-09-01
  • 2026-12-31

Top conditions

  • Alcohol Drinking13
  • Depression11
  • Alcohol Abuse10
  • HIV9
  • Alcohol Use Disorder8
  • Anxiety7
  • Prostate Cancer7
  • Smoking Cessation7

Frequently asked questions about Brown University

How many clinical trials does Brown University have on ClinicalTrials.gov?
Brown University is listed as the lead sponsor on 281 clinical trials in ClinicalTrials.gov, 56 of which are currently active (recruiting, enrolling, or ongoing).
How many of Brown University's trials are in Phase 3?
9 of Brown University's trials are in Phase 3, spread across 29 active drug programs.
What therapeutic areas does Brown University focus on?
Brown University's most-studied conditions on ClinicalTrials.gov are Alcohol Drinking, Depression, Alcohol Abuse, HIV, Alcohol Use Disorder.
When are Brown University's next clinical trial readouts?
Brown University has 10 upcoming primary-completion readouts tracked here; the soonest is “Adjuvant Nivolumab & Low Dose Ipilimumab for Stage III & Resected Stage IV Melanoma”, expected around 2019-03.